Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IntelliCap Performance Study with Metoprolol
NCT02025348Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2014
- Primary completion
- Mar 2014
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (4 arms), sponsored by AstraZeneca. Primary endpoint: In vivo performance up to 32 hours. Started Jan 2014; status: completed.
Beyond the preview
Go deeper on NCT02025348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025348.